Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 4, Pages e0123439
Publisher
Public Library of Science (PLoS)
Online
2015-04-22
DOI
10.1371/journal.pone.0123439
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TIMgenes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity
- (2015) Gordon J. Freeman et al. IMMUNOLOGICAL REVIEWS
- Unique Receptor Repertoire in Mouse Uterine NK cells
- (2014) H. Yadi et al. JOURNAL OF IMMUNOLOGY
- Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
- (2014) P. Sinha et al. JOURNAL OF IMMUNOLOGY
- Ly49 Receptors: Innate and Adaptive Immune Paradigms
- (2014) Mir Munir A. Rahim et al. Frontiers in Immunology
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire
- (2013) S. Sheppard et al. BLOOD
- Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
- (2013) Y.-J. Park et al. CANCER RESEARCH
- Tim-3/Galectin-9 Regulate the Homeostasis of Hepatic NKT Cells in a Murine Model of Nonalcoholic Fatty Liver Disease
- (2013) Z.-H. Tang et al. JOURNAL OF IMMUNOLOGY
- Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
- (2012) L. C. Ndhlovu et al. BLOOD
- Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
- (2012) M. K. Gleason et al. BLOOD
- Tim-3, a negative regulator of anti-tumor immunity
- (2012) Ana Carrizosa Anderson CURRENT OPINION IN IMMUNOLOGY
- Blockade of Tim-3 signaling restores the virus-specific CD8+T-cell response in patients with chronic hepatitis B
- (2012) Wei Wu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Taming dendritic cells with TIM-3: another immunosuppressive strategy used by tumors
- (2012) Jaina Patel et al. Immunotherapy
- TIM-3 Regulates Innate Immune Cells To Induce Fetomaternal Tolerance
- (2012) L. Chabtini et al. JOURNAL OF IMMUNOLOGY
- Regulation of pregnancy maintenance and fetal survival in mice by CD27low mature NK cells
- (2012) Khalil Karimi et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Reproductive immunology
- (2012) Ole B. Christiansen MOLECULAR IMMUNOLOGY
- Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface
- (2012) B. Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Emerging Role of the TIM Molecules in Transplantation
- (2011) M. Y. Yeung et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Maternal KIR and fetal HLA-C: a fine balance
- (2011) Olympe Chazara et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Unique Properties of Uterine NK Cells
- (2010) Irit Manaster et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B
- (2010) Ying Ju et al. JOURNAL OF HEPATOLOGY
- Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells
- (2010) V. Dardalhon et al. JOURNAL OF IMMUNOLOGY
- Human Pregnancy Up-Regulates Tim-3 in Innate Immune Cells for Systemic Immunity
- (2009) Jie Zhao et al. JOURNAL OF IMMUNOLOGY
- Evidence for participation of uterine natural killer cells in the mechanisms responsible for spontaneous preterm labor and delivery
- (2008) Shaun P. Murphy et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started